. Participant characteristics and demographics. Median (min, max) . AUC = area under the plasma concentration-time curve; C max = maximum observed plasma concentration; CVb = between subject coefficient of variation; FF = fluticasone furoate; N = total number of subjects who received this study medication, n = number of subjects for whom parameter derived; NA = not applicable; PK = pharmacokinetics; t 1/2 = terminal phase half-life; t last = time of last measurable concentration; t max = time to C max ; UMEC = umeclidinium; VI = vilanterol. 
